» Articles » PMID: 12941632

Loss of Distinct Arterial and Venous Boundaries in Mice Lacking Endoglin, a Vascular-specific TGFbeta Coreceptor

Overview
Journal Dev Biol
Publisher Elsevier
Date 2003 Aug 28
PMID 12941632
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Several characteristic morphological and functional differences distinguish arteries from veins. It was thought that hemodynamic forces shaped these differences; however, increasing evidence suggests that morphogenetic programs play a central role in blood vessel differentiation. Hereditary hemorrhagic telangiectasia (HHT) is a vascular dysplasia characterized by the inappropriate fusion of arterioles with venules. The genes implicated in this disease, ALK1 and endoglin, may be involved in defining the fundamental boundaries between arteries and veins. We previously showed that mice lacking Alk1 lost structural, molecular, and functional distinctions between arteries and veins. Here, we report that mice lacking endoglin develop arterial-venous malformations and fail to confine intraembryonic hematopoiesis to arteries. In contrast to Alk1 mutants, endoglin mutants do not show profound vessel dilation or downregulation of arterial ephrinB2. Finally, our data indicate that a failure in cardiac cushion formation observed in both strains may be secondary to the peripheral vasculature defect. The phenotypic similarities, yet reduced severity, implicates endoglin as an accessory coreceptor that specifically modulates Alk1 signaling. We propose that endoglin and Alk1 are necessary for the maintenance of distinct arterial-venous vascular beds and that attenuation of the Alk1 signaling pathway is the precipitating event in the etiology of HHT.

Citing Articles

From bench to bedside: murine models of inherited and sporadic brain arteriovenous malformations.

Ricciardelli A, Genet G, Genet N, McClugage 3rd S, Kan P, Hirschi K Angiogenesis. 2025; 28(2):15.

PMID: 39899215 PMC: 11790818. DOI: 10.1007/s10456-024-09953-5.


Vascular endothelial cell specification in health and disease.

Marziano C, Genet G, Hirschi K Angiogenesis. 2021; 24(2):213-236.

PMID: 33844116 PMC: 8205897. DOI: 10.1007/s10456-021-09785-7.


To be or not to be: endothelial cell plasticity in development, repair, and disease.

Greenspan L, Weinstein B Angiogenesis. 2021; 24(2):251-269.

PMID: 33449300 PMC: 8205957. DOI: 10.1007/s10456-020-09761-7.


Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia.

Bernabeu C, Bayrak-Toydemir P, McDonald J, Letarte M J Clin Med. 2020; 9(11).

PMID: 33167572 PMC: 7694477. DOI: 10.3390/jcm9113571.


Molecular regulation of arteriovenous endothelial cell specification.

Fang J, Hirschi K F1000Res. 2019; 8.

PMID: 31448079 PMC: 6668045. DOI: 10.12688/f1000research.16701.1.